{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:27:34Z","timestamp":1788532054208,"version":"build-2803163510"},"reference-count":61,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Guiding Science and Technology Project of Changsha Science and Technology Bureau","award":["kzd21095"],"award-info":[{"award-number":["kzd21095"]}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["2025JJ80448"],"award-info":[{"award-number":["2025JJ80448"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,15]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Observational research has produced varied results concerning the association between systemic lupus erythematosus (SLE) and coronary artery disease (CAD). This study employed a meta-analysis of cohort studies alongside a 2-sample Mendelian randomization (MR) method to investigate the causal influence of SLE on CAD risk. A comprehensive literature search was executed across PubMed, Web of Science, Embase, and the Cochrane Library, covering all pertinent cohort studies from their inception to August 14, 2024. The data regarding the causal association between SLE and CAD were synthesized using relative risk (RR), with results presented within a 95% confidence interval (CI). For MR analysis, data were derived from genome-wide association studies (GWAS) focusing on SLE and CAD in European and East Asian populations, respectively. The primary MR analysis employed the inverse-variance weighted (IVW) method, with the weighted median method and MR-Egger regression serving as complementary approaches. This meta-analysis included 13 cohort studies with a total of 2517,781 participants. The combined findings indicated that compared to the general or healthy population, individuals with SLE had a higher risk of developing CAD in the total population (RR [95% CI]\u2005=\u20052.355 [1.924\u20132.883], 95% prediction interval [PI]: 1.199\u20134.628). This association was also observed among European (RR [95% CI]\u2005=\u20052.028 [1.310\u20133.138], 95% PI: 0.539\u20137.631), East Asian (RR [95% CI]\u2005=\u20052.628 [1.698\u20134.067], 95% PI: 0.014\u2013487.335), and North American (RR [95% CI]\u2005=\u20052.711 [2.379\u20133.089], 95% PI: 2.193\u20133.352) groups. However, MR analysis utilizing the IVW method did not identify a genetically predicted causal relationship between SLE and CAD in either European or East Asian populations (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&gt;\u2005.05). Sensitivity analyses indicated an absence of heterogeneity or horizontal pleiotropy in the MR analysis. Findings from our meta-analysis indicated that SLE is associated with an elevated risk of CAD. Despite the lack of genetic evidence for a direct causal relationship between SLE and CAD, clinicians should remain vigilant and take proactive measures in monitoring CAD among SLE patients, considering the possible indirect effects of SLE on CAD risk.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048748","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:02:19Z","timestamp":1778896939000},"page":"e48748","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Causal relationship between systemic lupus erythematosus and coronary artery disease: Insights from a meta-analysis and Mendelian randomization"],"prefix":"10.1097","volume":"105","author":[{"given":"Ping","family":"Yuan","sequence":"first","affiliation":[{"name":"Department of Geriatrics, The Third Hospital of Changsha, Changsha, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, The Third Hospital of Changsha, Changsha, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Ge","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, The Third Hospital of Changsha, Changsha, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3324-842X","authenticated-orcid":false,"given":"Yan","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, The Third Hospital of Changsha, Changsha, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260904","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2147\/ITT.S377076","article-title":"Managing cardiovascular risk in systemic lupus erythematosus: considerations for the clinician.","volume":"12","author":"Semalulu","year":"2023","journal-title":"Immunotargets Ther"},{"key":"R2-20260904","first-page":"849684","article-title":"Lupus nephritis: an overview of recent findings.","volume":"2012","author":"de Zubiria Salgado","year":"2012","journal-title":"Autoimmune Dis"},{"key":"R3-20260904","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/rheumatology\/keab362","article-title":"All-cause and cause-specific mortality in systemic lupus erythematosus: a population-based study.","volume":"61","author":"Moghaddam","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"R4-20260904","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/0961203315627202","article-title":"Overall and cause-specific mortality in systemic lupus erythematosus: an updated meta-analysis.","volume":"25","author":"Lee","year":"2016","journal-title":"Lupus"},{"key":"R5-20260904","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.autrev.2004.04.002","article-title":"Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus.","volume":"3","author":"Borchers","year":"2004","journal-title":"Autoimmun Rev"},{"key":"R6-20260904","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.mayocp.2019.01.044","article-title":"Systemic lupus erythematosus and increased prevalence of atherosclerotic cardiovascular disease in hospitalized patients.","volume":"94","author":"Katz","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"R7-20260904","doi-asserted-by":"crossref","first-page":"100805","DOI":"10.1016\/j.xcrm.2022.100805","article-title":"Mendelian randomization and pathway analysis demonstrate shared genetic associations between lupus and coronary artery disease.","volume":"3","author":"Kain","year":"2022","journal-title":"Cell Rep Med"},{"key":"R8-20260904","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s11926-009-0035-z","article-title":"Epidemiology of atherosclerosis in systemic lupus erythematosus.","volume":"11","author":"Nikpour","year":"2009","journal-title":"Curr Rheumatol Rep"},{"key":"R9-20260904","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.semarthrit.2012.12.002","article-title":"The epidemiology of atherosclerotic cardiovascular disease among patients with SLE: a systematic review.","volume":"43","author":"Schoenfeld","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"R10-20260904","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1136\/heartjnl-2017-311279","article-title":"Association between chronic immune-mediated inflammatory diseases and cardiovascular risk.","volume":"104","author":"Baena-D\u00edez","year":"2018","journal-title":"Heart"},{"key":"R11-20260904","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/0003319720985337","article-title":"Myocardial infarction in systemic lupus erythematosus: incidence and coronary angiography findings.","volume":"72","author":"Tornvall","year":"2021","journal-title":"Angiology"},{"key":"R12-20260904","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1177\/0961203311425524","article-title":"Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study.","volume":"21","author":"Bengtsson","year":"2012","journal-title":"Lupus"},{"key":"R13-20260904","doi-asserted-by":"crossref","first-page":"107466","DOI":"10.1016\/j.intimp.2021.107466","article-title":"Patients with systemic lupus erythematosus face a high risk of cardiovascular disease: a systematic review and Meta-analysis.","volume":"94","author":"Lu","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"R14-20260904","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.amjms.2018.08.001","article-title":"Risk of coronary artery disease in patients with systemic lupus erythematosus: a systematic review and meta-analysis.","volume":"356","author":"Li","year":"2018","journal-title":"Am J Med Sci"},{"key":"R15-20260904","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s40471-017-0128-6","article-title":"Recent developments in mendelian randomization studies.","volume":"4","author":"Zheng","year":"2017","journal-title":"Curr Epidemiol Rep"},{"key":"R16-20260904","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data.","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"R17-20260904","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies.","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R18-20260904","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"R20-20260904","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/ijgo.15802","article-title":"Risk factors for postpartum urinary retention: an updated systematic review and meta-analysis.","volume":"168","author":"Li","year":"2025","journal-title":"Int J Gynaecol Obstet"},{"key":"R21-20260904","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1471-2288-11-41","article-title":"Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics.","volume":"11","author":"Bowden","year":"2011","journal-title":"BMC Med Res Methodol"},{"key":"R22-20260904","doi-asserted-by":"crossref","first-page":"e010247","DOI":"10.1136\/bmjopen-2015-010247","article-title":"Plea for routinely presenting prediction intervals in meta-analysis.","volume":"6","author":"IntHout","year":"2016","journal-title":"BMJ Open"},{"key":"R23-20260904","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis.","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"R24-20260904","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias.","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"R25-20260904","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test.","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"R26-20260904","doi-asserted-by":"crossref","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians.","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"key":"R27-20260904","doi-asserted-by":"crossref","first-page":"n2233","DOI":"10.1136\/bmj.n2233","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration.","volume":"375","author":"Skrivankova","year":"2021","journal-title":"BMJ"},{"key":"R28-20260904","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/s41588-021-00870-7","article-title":"Computationally efficient whole-genome regression for quantitative and binary traits.","volume":"53","author":"Mbatchou","year":"2021","journal-title":"Nat Genet"},{"key":"R29-20260904","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","article-title":"A cross-population atlas of genetic associations for 220 human phenotypes.","volume":"53","author":"Sakaue","year":"2021","journal-title":"Nat Genet"},{"key":"R30-20260904","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies.","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"key":"R31-20260904","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/sim.7221","article-title":"A framework for the investigation of pleiotropy in two-sample summary data Mendelian randomization.","volume":"36","author":"Bowden","year":"2017","journal-title":"Stat Med"},{"key":"R32-20260904","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R33-20260904","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/acr.23018","article-title":"Risk of myocardial infarction and stroke in newly diagnosed systemic lupus erythematosus: a general population-based study.","volume":"69","author":"Avi\u00f1a-Zubieta","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R34-20260904","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.24328","article-title":"Comparative risks of cardiovascular disease in patients with systemic lupus erythematosus, diabetes mellitus, and in general medicaid recipients.","volume":"72","author":"Barbhaiya","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R35-20260904","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.3899\/jrheum.090011","article-title":"Risk factors for development of coronary artery disease in women with systemic lupus erythematosus.","volume":"36","author":"Goldberg","year":"2009","journal-title":"J Rheumatol"},{"key":"R36-20260904","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/art.24537","article-title":"Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses\u2019 health study.","volume":"61","author":"Hak","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R37-20260904","first-page":"709","article-title":"The risk of cardiovascular morbidity and cardiovascular mortality in systemic lupus erythematosus and lupus nephritis: a Danish nationwide population-based cohort study.","volume":"56","author":"Hermansen","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"R38-20260904","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/acr.21782","article-title":"Association of systemic lupus erythematosus with angiographically defined coronary artery disease: a retrospective cohort study.","volume":"65","author":"Kaul","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R39-20260904","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1093\/rheumatology\/key233","article-title":"Progression of subclinical atherosclerosis in systemic lupus erythematosus versus rheumatoid arthritis: the impact of low disease activity.","volume":"57","author":"Kravvariti","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"R40-20260904","doi-asserted-by":"crossref","first-page":"e001993","DOI":"10.1136\/rmdopen-2021-001993","article-title":"Premature coronary artery disease in patients with immune-mediated inflammatory disease: a population-based study.","volume":"8","author":"Lai","year":"2022","journal-title":"RMD Open"},{"key":"R41-20260904","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1177\/0961203318804883","article-title":"Systemic lupus erythematosus is a risk factor for cardiovascular disease: a nationwide, population-based study in Korea.","volume":"27","author":"Lim","year":"2018","journal-title":"Lupus"},{"key":"R42-20260904","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.ijcard.2014.08.006","article-title":"Increased risk of acute myocardial infarction and mortality in patients with systemic lupus erythematosus: two nationwide retrospective cohort studies.","volume":"176","author":"Lin","year":"2014","journal-title":"Int J Cardiol"},{"key":"R43-20260904","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.12669\/pjms.36.6.2093","article-title":"Metabolic syndrome in systemic lupus erythematosus was closely related to body mass index, blood pressure, blood sugar, blood lipids, and arthritis.","volume":"36","author":"Jin","year":"2020","journal-title":"Pak J Med Sci"},{"key":"R44-20260904","doi-asserted-by":"crossref","first-page":"e0207520","DOI":"10.1371\/journal.pone.0207520","article-title":"Subclinical parameters of arterial stiffness and arteriosclerosis correlate with QRISK3 in systemic lupus erythematosus.","volume":"13","author":"V\u00e1zquez-Del Mercado","year":"2018","journal-title":"PLoS One"},{"key":"R45-20260904","first-page":"e33449","article-title":"Coronary artery disease in systemic lupus erythematosus: what do the facts say?","volume":"15","author":"Melano-Carranza","year":"2023","journal-title":"Cureus"},{"key":"R46-20260904","doi-asserted-by":"crossref","first-page":"269","DOI":"10.17219\/acem\/184868","article-title":"An update on cardiovascular disorders in systemic lupus erythematosus.","volume":"34","author":"P\u0119dzich","year":"2024","journal-title":"Adv Clin Exp Med"},{"key":"R47-20260904","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","article-title":"Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study.","volume":"145","author":"Manzi","year":"1997","journal-title":"Am J Epidemiol"},{"key":"R48-20260904","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.3899\/jrheum.161121","article-title":"Evolution of risk factors for atherosclerotic cardiovascular events in systemic lupus erythematosus: a longterm prospective study.","volume":"44","author":"Tselios","year":"2017","journal-title":"J Rheumatol"},{"key":"R49-20260904","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1191\/0961203305lu2200oa","article-title":"Cardiac involvement in systemic lupus erythematosus.","volume":"14","author":"Doria","year":"2005","journal-title":"Lupus"},{"key":"R50-20260904","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/01.ASN.0000132474.50966.DA","article-title":"Endothelial dysfunction.","volume":"15","author":"Endemann","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R51-20260904","first-page":"291","article-title":"Endothelial dysfunction and cardiovascular disease.","volume":"2014","author":"Widmer","year":"2014","journal-title":"Glob Cardiol Sci Pract"},{"key":"R52-20260904","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1177\/0961203317723716","article-title":"Increased adhesion molecule levels in systemic lupus erythematosus: relationships with severity of illness, autoimmunity, metabolic syndrome and cortisol levels.","volume":"27","author":"da Rosa Franchi Santos","year":"2018","journal-title":"Lupus"},{"key":"R53-20260904","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12969-019-0369-7","article-title":"Biomarkers associating endothelial Dysregulation in pediatric-onset systemic lupus erythematous.","volume":"17","author":"Lee","year":"2019","journal-title":"Pediatr Rheumatol Online J"},{"key":"R54-20260904","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.3899\/jrheum.101182","article-title":"Endothelium-dependent but not endothelium-independent flow-mediated dilation is significantly reduced in patients with systemic lupus erythematosus without vascular events: a metaanalysis and metaregression.","volume":"38","author":"Mak","year":"2011","journal-title":"J Rheumatol"},{"key":"R55-20260904","doi-asserted-by":"crossref","first-page":"7320","DOI":"10.1038\/s41598-017-07574-1","article-title":"Endothelial dysfunction in systemic lupus erythematosus - a case-control study and an updated meta-analysis and meta-regression.","volume":"7","author":"Mak","year":"2017","journal-title":"Sci Rep"},{"key":"R56-20260904","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2020.01.028","article-title":"Endothelial dysfunction and arterial stiffness in patients with systemic lupus erythematosus: a systematic review and meta-analysis.","volume":"297","author":"Mendoza-Pinto","year":"2020","journal-title":"Atherosclerosis"},{"key":"R57-20260904","doi-asserted-by":"crossref","first-page":"102863","DOI":"10.1016\/j.jaut.2022.102863","article-title":"Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus.","volume":"132","author":"Liu","year":"2022","journal-title":"J Autoimmun"},{"key":"R58-20260904","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1177\/0961203307081113","article-title":"Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort.","volume":"16","author":"Urowitz","year":"2007","journal-title":"Lupus"},{"key":"R59-20260904","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/art.23353","article-title":"Accumulation of coronary artery disease risk factors over three years: data from an international inception cohort.","volume":"59","author":"Urowitz","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R60-20260904","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/096120339700600610","article-title":"Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies.","volume":"6","author":"Borba","year":"1997","journal-title":"Lupus"},{"key":"R61-20260904","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.semarthrit.2015.10.010","article-title":"Dyslipidemia in systemic lupus erythematosus: just another comorbidity?","volume":"45","author":"Tselios","year":"2016","journal-title":"Semin Arthritis Rheum"},{"key":"R62-20260904","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3899\/jrheum.150460","article-title":"Optimal monitoring for coronary heart disease risk in patients with systemic lupus erythematosus: a systematic review.","volume":"43","author":"Tselios","year":"2016","journal-title":"J Rheumatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048748","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T14:02:39Z","timestamp":1788530559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000048748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":61,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048748","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"assertion":[{"value":"2025-01-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}